Related Experiment Video
Updated: Aug 10, 2026

Isolation of Cognate RNA-protein Complexes from Cells Using Oligonucleotide-directed Elution
Published on: January 16, 2017
[Interaction between RNA molecules of a two-componet trans-analog of antigenomic HDV-ribozyme]
Abstract:
Association of RNA molecules forming a two-component B:LS trans-analog of antigenomic HDV ribozyme was studied. From previously synthesized trans-ribozymes the B:LS ribozyme differs by length and sequence of its RNA molecules (33 and 34 bp, respectively), topology of functional parts and the absence of very short reaction product. The ribozyme displays a biphasic kinetics of self-cleavage similar to that of cis-ribozyme. Our original kinetic scheme for the B:LS trans-ribozyme self-cleavage (www.cardio.ru\labgen\RZ_e.html)describes a possible cause of biphasic nature of the reaction curve, namely, variation of the rate-limiting stage in the series of successive conformational transformations which coincide with the ribozyme self-cleavage. Interactions between the molecules involved in the reaction, i.e., "multimerization" of entire ribozyme and its components can be regarded as another cause of the biphasic kinetics. B:LS trans-ribozyme is a convenient model for the investigation of this process, since the binding of LS and B allows the formation of complexes with 1B:2LS or 2B:1LS stoichiometry and complexes with the cleavage products. We examined the factors determining dissociation-association of the ribozyme components using a series of electrophoreses under nondenaturing conditions. The possibility of interaction between cis- and transribozyme components was confirmed experimentally. In the presence of LS excess over B the ribozyme can form multimeres. These findings suggest the involvement of intermolecular interactions in native cis-ribozyme self-cleavage.
More Related Videos
Related Concept Videos
Leaky Scanning
Viruses with RNA Genomes
Ribozymes
Ribozymes can be...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi

